Endo In-licenses Novartis Pain Product
By Business Review Editor
Pharma Deals Review: Vol 2008 Issue 94 (Table of Contents)
Published: 8 Apr-2008
DOI: 10.3833/pdr.v2008.i94.193 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Endo Pharmaceuticals obtained the exclusive US marketing rights for the prescription NSAID Voltaren® Gel from Novartis for US$110 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS